Literature DB >> 33711983

Isolated thoracic intramedullary Erdheim-Chester disease presenting with paraplegia: a case report and literature review.

Ikchan Jeon1, Joon Hyuk Choi2.   

Abstract

BACKGROUND: Erdheim-Chester disease (ECD) is a rare, idiopathic, systemic non-Langerhans cell histiocytosis involving long bone and visceral organs. Central nervous system (CNS) involvement is uncommon and most cases develop as a part of systemic disease. We present a rare case of variant ECD as an isolated intramedullary tumor. CASE
PRESENTATION: A 75-year-old female patient with a medical history of diabetes and hypertension presented with sudden-onset flaccid paraparesis for 1 day. Neurological examination revealed grade 2-3 weakness in both legs, decreased deep tendon reflex, loss of anal tone, and numbness below T4. Leg weakness deteriorated to G1 before surgery. Preoperative magnetic resonance imaging (MRI) and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) showed an intramedullary mass lesion at T2-T4 with no systemic lesion, which was heterogeneous enhancement pattern with cord swelling and edema from C7 to T6. Gross total removal was achieved for the white-gray-colored and soft-natured intramedullary mass lesion with an ill-defined boundary. Histological finding revealed benign histiocytic proliferation with foamy histiocytes and uniform nuclei. We concluded it as an isolated intramedullary ECD. The patient showed self-standing and walkable at 18-month with no evidence of recurrence and new lesion on spine MRI and whole-body FDG-PET/CT until sudden occurrence of unknown originated thoracic cord infarction.
CONCLUSIONS: We experienced an extremely rare case of isolated intramedullary ECD, which was controlled by surgical resection with no adjuvant therapy. Histological examination is the most important for final diagnosis, and careful serial follow-up after surgical resection is required to identify the recurrence and progression to systemic disease.

Entities:  

Keywords:  Erdheim‐chester disease; Histiocytosis; Intramedullary; Spinal cord; Tumor

Mesh:

Substances:

Year:  2021        PMID: 33711983      PMCID: PMC7955615          DOI: 10.1186/s12891-021-04061-7

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  27 in total

1.  Spinal dural involvement in Erdheim-Chester disease: MRI findings.

Authors:  Sait Albayram; Osman Kizilkilic; Zuzan Zulfikar; Civan Islak; Naci Kocer
Journal:  Neuroradiology       Date:  2002-10-03       Impact factor: 2.804

2.  Erdheim-Chester disease associated with intramedullary spinal cord lesion.

Authors:  T Takeuchi; M Sato; T Sonomura; T Itakura
Journal:  Br J Radiol       Date:  2012-03       Impact factor: 3.039

3.  Erdheim-Chester disease presenting with an intramedullary spinal cord lesion.

Authors:  Charalampos Tzoulis; Ivar Otto Gjerde; Eirik Søfteland; Gesche Neckelmann; Eivind Strøm; Olav Karsten Vintermyr; Lisbeth Sviland; Martin Biermann
Journal:  J Neurol       Date:  2012-05-26       Impact factor: 4.849

Review 4.  Erdheim-Chester Disease: a comprehensive review of the literature.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Yehuda Shoenfeld
Journal:  Orphanet J Rare Dis       Date:  2013-09-08       Impact factor: 4.123

Review 5.  Non-Langerhans cell histiocytoses. A new unifying concept.

Authors:  B W Zelger; A Sidoroff; G Orchard; R Cerio
Journal:  Am J Dermatopathol       Date:  1996-10       Impact factor: 1.533

Review 6.  Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature.

Authors:  Florence Lachenal; François Cotton; Hélène Desmurs-Clavel; Julien Haroche; Hervé Taillia; Nadine Magy; Mohamed Hamidou; Juan Salvatierra; Jean-Charles Piette; Denis Vital-Durand; Hugues Rousset
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

Review 7.  Erdheim-Chester disease: a systematic review.

Authors:  Mauro Cives; Valeria Simone; Francesca Maria Rizzo; Franca Dicuonzo; Marirosa Cristallo Lacalamita; Giuseppe Ingravallo; Franco Silvestris; Franco Dammacco
Journal:  Crit Rev Oncol Hematol       Date:  2015-02-17       Impact factor: 6.312

8.  Pulmonary pathology of Erdheim-Chester disease.

Authors:  W L Rush; J A Andriko; F Galateau-Salle; E Brambilla; C Brambilla; I Ziany-bey; M L Rosado-de-Christenson; W D Travis
Journal:  Mod Pathol       Date:  2000-07       Impact factor: 7.842

Review 9.  Pulmonary and ophthalmic involvement with Erdheim-Chester disease: a case report and review of the literature.

Authors:  Timothy Craig Allen; Patricia Chevez-Barrios; Debra J Shetlar; Philip T Cagle
Journal:  Arch Pathol Lab Med       Date:  2004-12       Impact factor: 5.534

10.  Qualitative analysis of spinal intramedullary lesions using PET/CT.

Authors:  Kentaro Naito; Toru Yamagata; Hironori Arima; Junya Abe; Naohiro Tsuyuguchi; Kenji Ohata; Toshihiro Takami
Journal:  J Neurosurg Spine       Date:  2015-07-31
View more
  1 in total

Review 1.  Erdheim-Chester Disease with Isolated CNS Involvement: A Systematic Review of the Literature.

Authors:  Anam Haque; Carlos A Pérez; Thejasvi A Reddy; Rajesh K Gupta
Journal:  Neurol Int       Date:  2022-09-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.